2018
DOI: 10.1016/j.jocn.2018.09.009
|View full text |Cite
|
Sign up to set email alerts
|

FET PET in the evaluation of indeterminate brain lesions on MRI: Differentiating glioma from other non-neoplastic causes – A pilot study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
5
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 13 publications
0
5
0
Order By: Relevance
“…Figure 1 provides representative 18 F-FDOPA PET images of a brain inflammation case. Other dynamic amino acid PET studies also suggest that lymphomas (18) and benign lesions (19) show dynamic patterns similar to the ones observed in less aggressive gliomas. Dynamic PET imaging of brain lesions at the initial diagnosis, in addition to conventional static analysis (13), should therefore help identify nonglioma brain lesions.…”
mentioning
confidence: 58%
“…Figure 1 provides representative 18 F-FDOPA PET images of a brain inflammation case. Other dynamic amino acid PET studies also suggest that lymphomas (18) and benign lesions (19) show dynamic patterns similar to the ones observed in less aggressive gliomas. Dynamic PET imaging of brain lesions at the initial diagnosis, in addition to conventional static analysis (13), should therefore help identify nonglioma brain lesions.…”
mentioning
confidence: 58%
“…In the diagnostic setting, 18 F‐FET PET can identify both low‐grade and high‐grade brain tumours more accurately than 18 F‐FDG PET 4,5 . In patients with brain lesions of indeterminate nature on MRI, 18 F‐FET PET has shown a high positive predictive value aiding in clinical management 6 . The inability to distinguish between surgical changes, residual tumour and tumour recurrence is a major limitation of MRI.…”
Section: Introductionmentioning
confidence: 99%
“…4,5 In patients with brain lesions of indeterminate nature on MRI, 18 F-FET PET has shown a high positive predictive value aiding in clinical management. 6 The inability to distinguish between surgical changes, residual tumour and tumour recurrence is a major limitation of MRI. In treated brain tumours, 18 F-FET PET plays a significant role in detecting residual and recurrent disease.…”
Section: Introductionmentioning
confidence: 99%
“…In Europe, 18 F-FET is the most frequently used amino acid tracer for brain tumor imaging, and especially in Germany, some centers have collectively performed more than 20,000 examinations because of the high clinical interest in this method (11,12). Furthermore, the increasing number of publications coming from Australia, China, India, and South Korea indicate a wide acceptance of this method (13)(14)(15)(16)(17). For 18 F-FET, approval exists in Switzerland (18) and in France (IASOglio; IASON).…”
mentioning
confidence: 99%